This site is intended for healthcare professionals only
LoginRegister
Lupin bags tentative USFDA nod for rare autoimmune disorder drug AmifampridineLupin bags USFDA okay for seizure treatment drug Rufinamide
Novavax COVID jab shows high levels of protection against infection in two large phase-3 trialsNovavax COVID jab shows high levels of protection against infection in two large phase-3 trials
Sanofi halts breast cancer drug Amcenestrant clinical development programSanofi halts breast cancer drug Amcenestrant clinical development program
Molbio Diagnostics unveils Truenat RT-PCR test for HIVMolbio Diagnostics unveils Truenat RT-PCR test for HIV
Natco Pharma secures USFDA nod for Trabectedin for InjectionNatco Pharma secures USFDA nod for Trabectedin for Injection
5 arrested with banned cough syrup stockUP caps sale of codeine-based cough syrup, Tramadol based pain killer, Details
DCGI Chief Dr V G Somani tenure extended by 3 monthsDCGI Chief Dr V G Somani tenure extended by 3 months
Entresto Patent Expiry to Weigh on Novartis as Profit Seen Falling in 2026Novartis Lung cancer drug Canakinumab fails in Phase 3 trial
COVID-19: Bharat Biotech intranasal vaccine found safe in booster trialsCOVID-19: Bharat Biotech intranasal vaccine found safe in booster trials
UK first to approve Omicron COVID vaccine with Moderna approvalUK first to approve Omicron COVID vaccine with Moderna approval
Wockhardt begins Global Phase 3 clinical study of novel antibiotic WCK 5222Wockhardt begins Global Phase 3 clinical study of novel antibiotic WCK 5222
Serum institute CEO expects Omicron-specific vaccine in 6 months: ReportSerum institute CEO expects Omicron-specific vaccine in 6 months: Report
X